This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

ICON Launches New Functional Service Provision (FSP) Strategy

ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a new functional resourcing strategy delivered by a dedicated division, DOCS.

DOCS has been a leading provider of resourcing services to the global biopharmaceutical and medical device industry for over 15 years. To meet the growing demand for FSP solutions, DOCS has developed the FSP Delivery Platform™. This combines DOCS’ global resourcing engine with the processes, quality oversight, systems, and training and governance structures to drive productivity through flexible FSP models. The DOCS FSP Delivery Platform™ also leverages ICON’s extensive therapeutic, geographic and functional expertise to ensure greater efficiencies across customer programs.

“Functional resourcing and FSP continue to grow in popularity as sponsors look for innovative outsourcing strategies that enable them to gain efficiencies and accelerate the development of their pipelines,” commented Colin Stanley, President, DOCS. “DOCS’ core competency is providing highly talented teams with skills and experience that are aligned with the needs of our clients and which seamlessly integrate with their business. Our new FSP Delivery Platform builds on this competency and also allows clients to benefit from the breadth and depth of capabilities and expertise from the wider ICON organisation.”

The DOCS FSP business will be led by Barry Balfe, Vice President Global Program Management. Barry has 12 years of clinical research experience and has held leadership positions in both operations and business development for DOCS.

About DOCS

DOCS, a division of ICON plc, is a leading provider of global resourcing solutions to the pharmaceutical, biotechnology and medical device industries. The company specialises in four core service areas: Functional Service Provision, Contract Placement, Permanent Placement and Executive Search. DOCS has a global resourcing network and operational infrastructure across 82 locations in 40 countries enabling access to an extensive global pool of candidates. Further information is available at www.docsglobal.com



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs